Synthetic Biologics, Inc. (AEN) Reports that Flupirtine Sublicensee, Meda AB (MEDA-A.ST), to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
2/22/2013 8:58:12 AM
More...
|
Meda AB (MEDA-A.ST) (publ) – Year-End Report, January - December 2012
2/19/2013 6:24:52 AM
More...
|
Meda AB (MEDA-A.ST)'s Dymista Approved in Europe
1/24/2013 7:35:11 AM
More...
|
Meda AB (MEDA-A.ST) Acquires OTC Product in the U.S.
12/7/2012 11:01:27 AM
More...
|
Meda AB (MEDA-A.ST) (publ) – Interim Report, January–September 2012
11/9/2012 9:56:16 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Completes Sale of Its Women's Health Business to Meda AB (MEDA-A.ST)
10/16/2012 10:41:19 AM
More...
|
Meda AB (MEDA-A.ST): Acquisition of Women's Health Products Completed
10/16/2012 10:22:05 AM
More...
|
Meda AB (MEDA-A.ST): Nomination Committee Appointed
10/15/2012 10:16:16 AM
More...
|
Meda AB (MEDA-A.ST) Buys Women's Health Portfolio From Jazz Pharmaceuticals, plc (JAZZ) for $95 Million Cash
9/6/2012 10:38:20 AM
More...
|
European Commission (EC) Approves Meda AB (MEDA-A.ST)'s Zyclara
8/27/2012 8:18:46 AM
More...
|
|